ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 171 out of 890

$510K Total Retail Price of All Prescriptions

Rank: 241 out of 890

588 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

26% of this provider’s 588 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 9,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 533 371 S3 1 3
LISINOPRIL 482 405 2 4
NEXIUM 362 309 3 14
SIMVASTATIN 333 272 4 5
HYDROCHLOROTHIAZIDE 327 272 5 9
LEVOTHYROXINE SODIUM 301 231 6 2
OMEPRAZOLE 296 243 7 8
CITALOPRAM HBR 271 182 8 20
FUROSEMIDE 267 191 9 7
MELOXICAM 248 188 10 18
TRAMADOL HCL 239 200 11 16
PRAVASTATIN SODIUM 238 210 12 10
ZOLPIDEM TARTRATE 232 170 13 19
METFORMIN HCL 221 174 14 6
METOPROLOL TARTRATE 203 170 15 15
POTASSIUM CHLORIDE 200 166 16 11
AMLODIPINE BESYLATE 199 180 17 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 190 133 18 21
ATORVASTATIN CALCIUM 189 148 19 13
ATENOLOL 147 102 20 23
CEPHALEXIN 136 103 21 119
GLIPIZIDE 124 96 22 62
GABAPENTIN 119 74 23 12
AZITHROMYCIN 107 76 24 37
TAMSULOSIN HCL 106 96 25 32
ACETAMINOPHEN-CODEINE 103 70 S3 26 124
PROAIR HFA 102 84 27 55
PANTOPRAZOLE SODIUM 101 94 28 34
LOSARTAN-HYDROCHLOROTHIAZIDE 99 90 29 57
CLOPIDOGREL 96 89 30 28
ESCITALOPRAM OXALATE 95 85 31 51
CYCLOBENZAPRINE HCL 95 47 R 31 64
CELEBREX 91 61 33 91
METOPROLOL SUCCINATE 90 69 34 17
ESTRADIOL 89 65 R 35 118
DOXYCYCLINE HYCLATE 88 64 36 89
CIPROFLOXACIN HCL 79 63 37 58
NIFEDIPINE ER 78 53 38 75
ADVAIR DISKUS 74 66 39 52
PLAVIX 74 69 39 42
LEVOFLOXACIN 71 44 41 107
CLONIDINE HCL 70 37 42 35
CARVEDILOL 69 64 43 22
AMITRIPTYLINE HCL 67 28 R 44 43
MECLIZINE HCL 67 52 44 97
WARFARIN SODIUM 67 43 44 24
SULINDAC 63 45 47 292
ROPINIROLE HCL 60 60 48 93
GLYBURIDE-METFORMIN HCL 57 35 R 49 115
SERTRALINE HCL 56 38 50 26
DONEPEZIL HCL 55 54 51 30
CRESTOR 54 41 52 25
DETROL LA 52 52 53 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.